Experiment 1218978
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | ANON:. (1990). HYPERICIN: ARC/AIDS STUDY PROTOCOL: PHASE I DOSE ESCALATING TRIAL.. 4(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | AN ANNOUNCEMENT OF A CLINICAL TRIAL WITH THE TITLE COMPOUND AT NEW YORK UNIVERSITY WITH A DOSE ESCALATING FROM 0.25 MG/KG DAILY. EXCLUSION CRITERIA: ANTI-RETROVIRAL THERAPY WITHIN 1 MONTH, LYMPHOMA, CHRONIC THREAPY FOR OPPORTUNISTIC INFECTIONS. INCLUSION CRITERIA: PLATELETS GREATER THAN 75,000, SGOT/TP LESS THAN 2.5 TIMES NORMAL, HEMOGLOBIN LESS THAN 9.5. NUMBER OF SUBJECTS IN THE TRIAL WILL BE 35. STARTING DATE: OCTOBER, 1990. |
| Dose amount | 0.25 MG |
| Number | 1 |
| Qualitative result | . |
| Animal | HUMAN ADULT |
| Per unit | KG |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |